Treatment for<unk>  will depend on the underlying cause. When evaluating a patient for cyanosis or respiratory distress, vital signs should be monitored, especially the patient's heart rate and oxygen saturation. It is beneficial to have vascular access established. In newborns, the pulse oximeter is typically placed on the right hand to determine pre-ductal oxygenation, referring to oxygenation before the ductus arteriosus (connection between aorta and pulmonary artery). This gives the oxygenation level the heart and brain receive. Traditionally, supplemental oxygen is given in an escalating manner beginning with free-flowing oxygen, progressing to positive pressure ventilation or continuous positive airway pressure, and ending with mechanical intubation. The goal oxygen saturation is between 85 and 95%. If an infant requires supplemental oxygen for a prolonged time it should be heated and humidified to avoid heat loss. Cyanotic heart disease Some babies born with cyanotic heart disease are treated with prostaglandin E1 after birth to keep the ductus arteriosus open and allow for more oxygenated blood to be pumped to the body. Many also receive oxygen therapy to increase the percentage of oxygen in the blood. Most of these babies will require surgery during infancy to correct their structural heart defect. Severe methemoglobinemia The first-line treatment for severe methemoglobinemia is methylene<unk> , a medication that will reduce methemoglobin in the blood. This is possible because methylene<unk>  oxidizes NADPH, which in turn can convert methemoglobin back to hemoglobin.
Blue baby syndrome
Gray baby syndrome
Michelin tire baby syndrome
Shaken baby syndrome
Omphalitis of newborn
Neonatal diabetes
Neonatal jaundice
Hemolytic disease of the newborn